0000950170-24-009496.txt : 20240131 0000950170-24-009496.hdr.sgml : 20240131 20240131173018 ACCESSION NUMBER: 0000950170-24-009496 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240129 FILED AS OF DATE: 20240131 DATE AS OF CHANGE: 20240131 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DOYLE THOMAS JAMES CENTRAL INDEX KEY: 0001910331 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37620 FILM NUMBER: 24584078 MAIL ADDRESS: STREET 1: C/O KURA ONCOLOGY, INC. STREET 2: 12730 HIGH BLUFF DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kura Oncology, Inc. CENTRAL INDEX KEY: 0001422143 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 611547851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 500-8800 MAIL ADDRESS: STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: ZETA ACQUISITION CORP III DATE OF NAME CHANGE: 20071227 4 1 ownership.xml 4 X0508 4 2024-01-29 0001422143 Kura Oncology, Inc. KURA 0001910331 DOYLE THOMAS JAMES C/O KURA ONCOLOGY, INC. 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 false true false false SVP, Finance & Accounting false Common Stock 2024-01-29 4 S false 594 17.8005 D 49817 D Common Stock 2024-01-29 4 S false 761 17.8005 D 49056 D Common Stock 2024-01-29 4 S false 963 17.8005 D 48093 D Common Stock 500 I spouse's 401(k) Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22. Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/7/22. Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23. Teresa Bair, Attorney-in-fact for Thomas Doyle 2024-01-31